74 American Society of Anesthesiologists physical status (ASA) I or II patients undergoing gynecological laparoscopic surgery were randomly allocated to TEAS or control groups.
Sample Count
74
Age
18-60
Control
Sham
control group(n=37)
Experiment
TEAS group(n=37)
Indicator
QuestionnairePostoperative pain scoresPostoperative Nausea and Vomiting(PONV)Duration of PACU stayPatient satisfaction
Auxiliary Medication
All patients were fasted for at least 8 h and premedicated with IV midazolam 0.05 mg/kg 30 min before anesthesia induction. General anesthesia was induced with IV sufentanil 0.5 μg/kg and propofol 2.0 mg/kg. Tracheal intubation was facilitated with cisatracurium 0.15 mg/kg. Anesthesia maintenance was achieved with sevoflurane 2%-3% according to both hemodynamic parameters and bispectral index (BIS) of 40–60. All patients received IV tropisetron 5 mg 30 min before the end of surgery. Neuromuscular blockade was antagonized using neostigmine 0.02 mg/kg and atropine 0.01 mg/kg.
Stimulation Method
TEAS
Induction Method
Electroacupuncture Instrument Model
Manufacturer
Frequency
Waveform
Strength
Induction Time
HANS-100B
Nanjing Jisheng Medical Technology Co., Ltd., Nanjing, Jiangsu, China
2/10 Hz
dense-disperse frequency
6-9 mA
30 min
Acupuncture_Needle
Needle_Manufacturer
Needle_Depth
-
-
-
Description TEAS was performed with a dense-disperse frequency of 2/10 Hz and an intensity of 6–9 mA for 30 min using the Hans electronic acupuncture apparatus (HANS-100B, Nanjing Jisheng Medical Technology Company, Nanjing, China). The optimal intensity was adjusted to maintain a slight twitching of the regional muscle according to individual maximum tolerance.
Anesthesia Method
GA
Clinical Trial Type
random
Effector
The TEAS group had higher QoR scores than control group upon 24 h after surgery (177 versus 165; P < 0.001). Compared with the control group, postoperative pain scores and the cumulative number of opioids administered were lower in the TEAS group patients (P = 0.04). TEAS reduced the incidence of PONV and dizziness, as well as duration of PACU stay. Simultaneously, the patient's satisfaction scores were higher in the TEAS group (P = 0.002). Conclusion. Preoperative TEAS enhances QoR, improves postoperative analgesia and patient's satisfaction, alleviates postoperative side effects, and accelerates discharge after general anesthesia for gynecological laparoscopic surgery.
Transcutaneous Electrical Acupoint Stimulation Improves the Postoperative Quality of Recovery and Analgesia after Gynecological Laparoscopic Surgery: A Randomized Controlled Trial.
Abstract
Background. We conducted this prospective, randomized, double-blind, placebo-controlled study to evaluate the effects of transcutaneous electric acupoint stimulation (TEAS) on the quality of recovery (QoR) and postoperative analgesia after gynecological laparoscopic surgery. Methods. 74 American Society of Anesthesiologists physical status (ASA) I or II patients undergoing gynecological laparoscopic surgery were randomly allocated to TEAS or control groups. The primary outcome was the quality of recovery, which was assessed on the day before surgery and 24 h after surgery using a 40-item questionnaire. Secondary outcomes included postoperative pain scores, the incidence of postoperative nausea and vomiting (PONV), duration of postanesthesia care unit (PACU) stay, and patient's satisfaction. Results. The TEAS group had higher QoR scores than control group upon 24 h after surgery (177 versus 165; P < 0.001). Compared with the control group, postoperative pain scores and the cumulative number of opioids administered were lower in the TEAS group patients (P = 0.04). TEAS reduced the incidence of PONV and dizziness, as well as duration of PACU stay. Simultaneously, the patient's satisfaction scores were higher in the TEAS group (P = 0.002). Conclusion. Preoperative TEAS enhances QoR, improves postoperative analgesia and patient's satisfaction, alleviates postoperative side effects, and accelerates discharge after general anesthesia for gynecological laparoscopic surgery."
Souce
Evid Based Complement Alternat Med. 2015;2015:324360. doi: 10.1155/2015/324360. Epub 2015 Jun 11.
